Evidence map›Paper›PMID 34270621›Full record

ArticlePloS one2021

Retrospective analysis of demographic factors in COVID-19 patients entering the Mount Sinai Health System.

Abrisham Eskandari, Agnieszka Brojakowska, Malik Bisserier, Jeffrey Bander, Venkata Naga Srikanth Garikipati, Lahouaria Hadri, David Goukassian, Kenneth Fish

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Association between COVID-19 and outstanding academic performance at a Spanish university.Archives of public health = Archives belges de sante publique · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. The Impact of COVID-19 in the Latinx Community.HCA healthcare journal of medicine · 2022
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abrisham EskandariCardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Agnieszka BrojakowskaCardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.ORCID 0000-0002-7319-9685
Malik BisserierCardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.ORCID 0000-0001-8826-4649
Jeffrey BanderCardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Venkata Naga Srikanth GarikipatiDepartment of Emergency Medicine, Ohio State University Wexner Medical Center, Columbus, OH, United States of America.ORCID 0000-0001-5803-5335
Lahouaria HadriCardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
David GoukassianCardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Kenneth FishCardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.ORCID 0000-0002-7781-0314

Funding

TRAINING PROGRAM IN MOLECULAR AND CELLULAR CARDIOLOGYT32HL007824 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GELB, BRUCE D · 1995 to 2022
$8.6M
Therapeutic Mechanisms of Cardiac Progenitors in Ischemic CardiomyopathyR01HL135093 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FISH, KENNETH MICHAEL, KOVACIC, JASON CIRIL · 2017 to 2020
$3.4M
Interactions of SERCA2a and BMPRII in Vascular DiseaseR01HL133554 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HADRI, LAHOUARIA · 2016 to 2020
$2.3M
Role of Epac1 in the Pathogenesis of Pulmonary FibrosisR01HL158998 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Lahouaria HADRI · 2022 to 2026
$2.1M
VACCINATION BY TOPICAL APPLICATION OF CONDENSED DNAR43IP000005 · IP · COPERNICUS THERAPEUTICS, INC. · PI COOPER, MARK J · 2000 to 2000
–
NCIRD CDC HHS R43 IP000005NHLBI NIH HHS R01 HL133554NHLBI NIH HHS R01 HL135093NHLBI NIH HHS R01 HL158998NHLBI NIH HHS T32 HL007824NIH HHS HL135093
6 · The paper itself

Abstract

With the continued rise of the global incidence of COVID-19 infection and emergent second wave, the need to understand characteristics that impact susceptibility to infection, clinical severity, and outcomes remains vital. The objective of this study was to assess modifying effects of demographic factors on COVID-19 testing status and outcomes in a large, diverse single health system cohort. The Mount Sinai Health System de-identified COVID-19 database contained records of 39,539 patients entering the health system from 02/28/2020 to 06/08/2020 with 7,032 laboratory-confirmed cases. The prevalence of qRT-PCR nasopharyngeal swabs (χ2 = 665.7, p<0.0001) and case rates (χ2 = 445.3, p<0.0001) are highest in Hispanics and Black or African Americans. The likelihood of admission and/or presentation to an intensive care unit (ICU) versus non-ICU inpatient unit, emergency department, and outpatient services, which reflects the severity of the clinical course, was also modified by race and ethnicity. Females were less likely to be tested [Relative Risk(RR) = 1.121, p<0.0001], and males had a higher case prevalence (RR = 1.224, p<0.001). Compared to other major ethnic groups, Whites experienced a higher prevalence of mortality (p<0.05). Males experienced a higher risk of mortality (RR = 1.180, p = 0.0012) at relatively younger ages (70.58±11.75) compared to females (73.02±11.46) (p = 0.0004). There was an increased severity of disease in older patient populations of both sexes. Although Hispanic and Black or African American race was associated with higher testing prevalence and positive testing rates, the only disparity with respect to mortality was a higher prevalence in Whites.

Indexed as

AdultAgedAged, 80 and overCOVID-19EthnicityFemaleHealth Information SystemsHumansMaleMiddle AgedNew YorkPatient AdmissionRace FactorsSex Factors

Identifiers

PMID34270621
PMCPMC8284665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.